Arena Pharmaceuticals (ARNA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2021 | 12-2020 | 12-2019 | 12-2018 | 12-2017 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -616,433 | -404,734 | 397,555 | -29,399 | -92,732 |
| Depreciation Amortization | 8,119 | 5,408 | -2,395 | 3,205 | 4,414 |
| Income taxes - deferred | N/A | N/A | 110,333 | -110,333 | 0 |
| Accounts receivable | 1,101 | 344 | 3,432 | -2,760 | 10,787 |
| Other Working Capital | 23,179 | -1,487 | 6,208 | -10,119 | 8,197 |
| Other Operating Activity | 132,018 | 47,375 | 53,561 | 17,194 | 2,692 |
| Operating Cash Flow | $-452,016 | $-353,094 | $568,694 | $-132,212 | $-66,642 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -988 | -820 | -4,819 | -692 | 676 |
| Purchase Of Investment | -612,218 | -1,033,665 | -1,469,220 | -364,539 | -112,615 |
| Sale Of Investment | 1,004,607 | 1,014,083 | 976,093 | 110,564 | N/A |
| Other Investing Activity | -70,000 | -1,000 | 997 | 3,394 | -451 |
| Investing Cash Flow | $321,401 | $-21,402 | $-496,949 | $-251,273 | $-112,390 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -4,401 | -3,815 | -3,282 | -4,000 | -3,518 |
| Common Stock Issued | 139,808 | 354,421 | 13,147 | 389,031 | 248,805 |
| Financing Cash Flow | $135,407 | $350,606 | $9,865 | $385,031 | $245,287 |
| Exchange Rate Effect | 236 | 160 | -10 | 654 | 1,870 |
| Beginning Cash Position | 219,770 | 243,500 | 161,900 | 159,700 | 91,575 |
| End Cash Position | 224,798 | 219,770 | 243,500 | 161,900 | 159,700 |
| Net Cash Flow | $5,028 | $-23,730 | $81,600 | $2,200 | $68,125 |
| Free Cash Flow | |||||
| Operating Cash Flow | -452,016 | -353,094 | 568,694 | -132,212 | -66,642 |
| Capital Expenditure | -988 | -820 | -4,819 | -692 | -113 |
| Free Cash Flow | -453,004 | -353,914 | 563,875 | -132,904 | -66,755 |